Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About Institute of Biomedical Research Corp. (OTC: MRES)
The Institute of BioMedical Research is a biomedically ambitious business venture whose activities extend from highly diversified scientific research and sophisticated services research and development, quality control and standardisation of pharmaceuticals, cosmetics and food products up to major long term biomedical and environmental research projects, as well as the development of new diagnostic technologies and innovative experimental medical treatments. Regulatory certification of new drugs and biomedical products also constitutes important business activities of the Institute. The Institute is essential for the development of Montenegro within the regional and European environment.
- Drasko Pekovic / President, CEO
- Drasko Pekovic /
Current Share Structure
- Market Cap: $1,015,537 - 03/16/2018
- Authorized: 2,000,000,000 - 12/31/2014
- Issue and Outstanding: 846,280,777 - 12/31/2014
- Float: 344,995,907 - 09/05/2014
Daily Technical Chart for (OTC: MRES)
Stay tuned for daily updates and more on (OTC: MRES)
More to come on (OTC: MRES)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MRES is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MRES and does not buy, sell, or trade any shares of MRES. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/